임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
33건 표시
- 3상모집 중· Diphtheria-Tetanus-acellular Pertussis VaccinesA Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years
리드: GSK
- 3상모집 중· Diphtheria-Tetanus-acellular Pertussis VaccinesA Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women
리드: GSK
- 3상모집 중· Non-alcoholic Fatty Liver DiseaseA Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
리드: GSK
- 3상모집 중· Gastrointestinal NeoplasmsA Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
리드: GSK
- 3상모집 중· Refractory Chronic CoughA 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension
리드: GSK
- 3상모집 중· Respiratory Syncytial Virus InfectionsA Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
리드: GSK
- 3상모집 중· Non-alcoholic Fatty Liver DiseaseA Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
리드: GSK
- 3상모집 중· Pulmonary Disease, Chronic ObstructiveeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
리드: GSK
- 3상모집 중· Neoplasms, LungA Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
리드: GSK
- 3상모집 중· Pulmonary Disease, Chronic ObstructiveDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
리드: GSK
- 3상모집 중· Pulmonary Disease, Chronic ObstructiveDepemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
리드: GSK
- 3상모집 중· Plasmodium Vivax MalariaFocaL Mass Drug Administration for Vivax Malaria Elimination
협력: GSK
- 3상모집 중· Lung Diseases, InterstitialA Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
리드: GSK
- 3상모집 중· Stage III Ovarian CancerHeated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
협력: GSK
- 3상모집 중· Kidney Transplant Recipient Response to Shingrix VaccineShingrix in Renal Transplant Recipients
협력: GSK
- 3상모집 중· Primary Immune Thrombocytopenia (ITP)Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
협력: GSK
- 3상모집 중· Hypereosinophilic SyndromeDepemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
리드: GSK
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.